The patient-centered medical home (PCMH) has many key goals and components. When paneled, the majority of AMCP 2013 Nexus attendees agreed that the PCMH is best described as a practice model that organizes primary care practice operations and incentives to deliver patient-centered, coordinated, comprehensive care with the goal of improved quality and efficiency.
The patient-centered medical home (PCMH) has many key goals and components. When paneled, the majority of AMCP 2013 Nexus attendees agreed that the PCMH is best described as “a practice model that organizes primary care practice operations and incentives to deliver patient-centered, coordinated, comprehensive care with the goal of improved quality and efficiency.” With health reform, and the emergence of novel practice models, managed care organizations are increasingly identifying ways in which pharmacist involvement can help to improve the quality and cost-effectiveness of patient care.
Stephanie Ross, PharmD, BCACP, primary care clinical pharmacist, Capital District Physicians’ Health Plan, Inc (CDPHP), says that 5 years ago, CDPHP recognized that primary care was in crisis. The predicament included a projected shortage of primary care physicians, and a model of care that did not offer competitive earnings to attract the interest of graduating students. This provided incentive for CDPHP to support enhanced reimbursement to primary care practices, as well as to make the profession more attractive for medical students. Dr Ross said that one of the reasons we need pharmacists to participate in the model home is that more than 80% of treatments involve some form of medication. Furthermore, an aging population with more comorbid/complex disease will require complex individualized treatment strategies.
Beyond the triple aim, pharmacists can collaboratively support high-quality and cost-effective care in a multitude of ways. Dr Ross suggests those include chronic use of PPIs/PPI step-down protocol, proper management of common acute care illnesses, hypertension treatment education, diabetes resources, and miscellaneous drug conversions. In CDPHP’s next phase of embedding the managing clinical pharmacist into primary care practice, they hope to focus on population management/population health, expand primary care clinical pharmacy services to more medical groups, and establish best practices among providers in the community including quality, satisfaction, and cost.
Alex C. Bitting, PharmD, VRx Pharmacy Services, relayed one provider’s feedback about the importance of pharmacy involvement with the PCMH. “Having a clinical pharmacist available on site has supplemented the care I am able to provide my patients. The pharmacist is able to take time to educate patients not only on medications prescribed, but also how the body responds to each medication,” said Erica Baiden, MD, family medicine. “I also appreciate having another pair of eyes to offer my patients quality and comprehensive care.”
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, chief medical officer, the Access Group, added that just as pharmacists play a critical role in medication adherence, the pharmacy can also play an equal role in medication access and management. The retail pharmacy can improve timing and location of delivery, as well as play a critical role in adherence through medication dispersing services.
Dr Stefanacci says what is critical for managed care organizations is the identification of both the “right patient and the right intervention.”
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More